BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 19433342)

  • 1. Didanosine ester prodrugs: synthesis, albumin binding properties and pharmacokinetic studies in rats.
    Høyem S; Bruheim S; Maelandsmo G; Olberg DE; Brudeli B; Asberg A; Klaveness J; Rongved P
    Eur J Med Chem; 2009 Oct; 44(10):3874-9. PubMed ID: 19433342
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bifunctional peptidomimetic prodrugs of didanosine for improved intestinal permeability and enhanced acidic stability: synthesis, transepithelial transport, chemical stability and pharmacokinetics.
    Yan Z; Sun J; Chang Y; Liu Y; Fu Q; Xu Y; Sun Y; Pu X; Zhang Y; Jing Y; Yin S; Zhu M; Wang Y; He Z
    Mol Pharm; 2011 Apr; 8(2):319-29. PubMed ID: 21280612
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and biological evaluation of two glycerolipidic prodrugs of didanosine for direct lymphatic delivery against HIV.
    Lalanne M; Paci A; Andrieux K; Dereuddre-Bosquet N; Clayette P; Deroussent A; Ré M; Vassal G; Couvreur P; Desmaële D
    Bioorg Med Chem Lett; 2007 Apr; 17(8):2237-40. PubMed ID: 17276686
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro and in vivo evaluation of 6-azido-2',3'-dideoxy-2'-fluoro-beta-D-arabinofuranosylpurine and N6-methyl-2',3'-dideoxy-2'-fluoro-beta-D-arabinofuranosyladenine as prodrugs of the anti-HIV nucleosides 2'-F-ara-ddA and 2'-F-ara-ddI.
    Koudriakova T; Manouilov KK; Shanmuganathan K; Kotra LP; Boudinot FD; Cretton-Scott E; Sommadossi JP; Schinazi RF; Chu CK
    J Med Chem; 1996 Nov; 39(23):4676-81. PubMed ID: 8917656
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lipophilic, acid-stable, adenosine deaminase-activated anti-HIV prodrugs for central nervous system delivery. 3. 6-Amino prodrugs of 2'-beta-fluoro-2',3'-dideoxyinosine.
    Driscoll JS; Siddiqui MA; Ford H; Kelley JA; Roth JS; Mitsuya H; Tanaka M; Marquez VE
    J Med Chem; 1996 Apr; 39(8):1619-25. PubMed ID: 8648601
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro stability and in vivo pharmacokinetic studies of a model opioid peptide, H-Tyr-D-Ala-Gly-Phe-D-Leu-OH (DADLE), and its cyclic prodrugs.
    Yang JZ; Chen W; Borchardt RT
    J Pharmacol Exp Ther; 2002 Nov; 303(2):840-8. PubMed ID: 12388671
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantitative determination of zidovudine diaryl phosphate triester pro-drugs in rat plasma by high-performance liquid chromatography-electrospray ionization tandem mass spectrometry.
    Zhu M; Xie B; Tang G; Hu A; Fang M; Wu Z; Zhao Y
    J Pharm Biomed Anal; 2008 Dec; 48(5):1417-24. PubMed ID: 19118970
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabolism evaluation of biomimetic prodrugs by in vitro models and mass spectrometry.
    Lalanne M; Khoury H; Deroussent A; Bosquet N; Benech H; Clayette P; Couvreur P; Vassal G; Paci A; Andrieux K
    Int J Pharm; 2009 Sep; 379(2):235-43. PubMed ID: 19467308
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lymphatic targeting of anti-HIV nucleosides: distribution of 2',3'-dideoxyinosine after intravenous and oral administration of dipalmitoylphosphatidyl prodrug in mice.
    Manouilov KK; Xu ZS; Boudinot FD; Schinazi RF; Chu CK
    Antiviral Res; 1997 May; 34(3):91-9. PubMed ID: 9191016
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulating the alky chain length of fatty acid-didanosine prodrugs and evaluating its role in albumin binding.
    Chen H; Wang G; Sun L; Zhang H; Sun M; Sun J; Shang L; Luo C
    Drug Deliv Transl Res; 2018 Feb; 8(1):21-31. PubMed ID: 28944416
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The safety profile and antiviral activity of the combination of stavudine, didanosine, and nelfinavir in patients with HIV infection.
    Elion R; Kaul S; Knupp C; Adler M; Cross AP; Dunkle LM; Kelleher T
    Clin Ther; 1999 Nov; 21(11):1853-63. PubMed ID: 10890257
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A new nanomedicine based on didanosine glycerolipidic prodrug enhances the long term accumulation of drug in a HIV sanctuary.
    Skanji R; Andrieux K; Lalanne M; Caron J; Bourgaux C; Degrouard J; Brisset F; Gueutin C; Chacun H; Dereuddre-Bosquet N; Paci A; Vassal G; Bauduin L; Garcia-Argote S; Rousseau B; Clayette P; Desmaële D; Couvreur P
    Int J Pharm; 2011 Jul; 414(1-2):285-97. PubMed ID: 21596125
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drug-drug and drug-food interactions between tenofovir disoproxil fumarate and didanosine.
    Kearney BP; Sayre JR; Flaherty JF; Chen SS; Kaul S; Cheng AK
    J Clin Pharmacol; 2005 Dec; 45(12):1360-7. PubMed ID: 16291710
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics of didanosine in antepartum and postpartum human immunodeficiency virus--infected pregnant women and their neonates: an AIDS clinical trials group study.
    Wang Y; Livingston E; Patil S; McKinney RE; Bardeguez AD; Gandia J; O'Sullivan MJ; Clax P; Huang S; Unadkat JD
    J Infect Dis; 1999 Nov; 180(5):1536-41. PubMed ID: 10515813
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Design, synthesis, and anti-inflammatory evaluation of a series of novel amino acid-binding 1,5-diarylpyrazole derivatives.
    Li MH; Yin LL; Cai MJ; Zhang WY; Huang Y; Wang X; Zhu XZ; Shen JK
    Acta Pharmacol Sin; 2005 Jul; 26(7):865-72. PubMed ID: 15960895
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Absorption and intestinal metabolism of purine dideoxynucleosides and an adenosine deaminase-activated prodrug of 2',3'-dideoxyinosine in the mesenteric vein cannulated rat ileum.
    Singhal D; Ho NF; Anderson BD
    J Pharm Sci; 1998 May; 87(5):569-77. PubMed ID: 9572907
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis, in vitro anti-human immunodeficiency virus structure-activity relationships and biological stability of 5'-O-myristoyl analogue derivatives of 3'-azido-2',3'-dideoxythymidine (AZT) as potential prodrugs.
    Parang K; Wiebe LI; Knaus EE
    Antivir Chem Chemother; 1998 Jul; 9(4):311-23. PubMed ID: 9875410
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prodrugs of HIV protease inhibitors-saquinavir, indinavir and nelfinavir-derived from diglycerides or amino acids: synthesis, stability and anti-HIV activity.
    Gaucher B; Rouquayrol M; Roche D; Greiner J; Aubertin AM; Vierling P
    Org Biomol Chem; 2004 Feb; 2(3):345-57. PubMed ID: 14747863
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhanced brain delivery of an anti-HIV nucleoside 2'-F-ara-ddI by xanthine oxidase mediated biotransformation.
    Shanmuganathan K; Koudriakova T; Nampalli S; Du J; Gallo JM; Schinazi RF; Chu CK
    J Med Chem; 1994 Mar; 37(6):821-7. PubMed ID: 8145233
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Amino acid ester prodrugs of 2-bromo-5,6-dichloro-1-(beta-D-ribofuranosyl)benzimidazole enhance metabolic stability in vitro and in vivo.
    Lorenzi PL; Landowski CP; Song X; Borysko KZ; Breitenbach JM; Kim JS; Hilfinger JM; Townsend LB; Drach JC; Amidon GL
    J Pharmacol Exp Ther; 2005 Aug; 314(2):883-90. PubMed ID: 15901797
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.